Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2023.11.001 ↗Kurz gefasst
Leserbrief in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Fabio Salvatore Macaluso und 1 weiteren Autor:innen. Beteiligte Einrichtung: IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy. Electronic address: fsmacaluso@gmail.com. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy. Electronic address: fsmacaluso@gmail.com.
- IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy.
Zitieren
APA
Macaluso, F. S., & Orlando, A. (2024). Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.11.001
Vancouver
Macaluso FS, Orlando A. Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2023.11.001
BibTeX
@article{Macaluso2024,
author = {Macaluso, Fabio Salvatore and Orlando, Ambrogio},
title = {Author's reply: “Tofacitinib in ulcerative colitis—Small molecule but large effect”},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2023.11.001}
}
EUVIMED